<SEC-DOCUMENT>0001140361-22-040942-index.html : 20221110 <SEC-HEADER>0001140361-22-040942.hdr.sgml : 20221110 <ACCEPTANCE-DATETIME>20221110161926 ACCESSION NUMBER: 0001140361-22-040942 CONFORMED SUBMISSION TYPE: DEFM14A PUBLIC DOCUMENT COUNT: 7 FILED AS OF DATE: 20221110 DATE AS OF CHANGE: 20221110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Metacrine, Inc. CENTRAL INDEX KEY: 0001634379 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472297384 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFM14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39512 FILM NUMBER: 221377528 BUSINESS ADDRESS: STREET 1: 4225 EXECUTIVE SQUARE STREET 2: SUITE 600 CITY: SAN DIEGO STATE: CA ZIP: 92037 BUSINESS PHONE: 858-369-7800 MAIL ADDRESS: STREET 1: 4225 EXECUTIVE SQUARE STREET 2: SUITE 600 CITY: SAN DIEGO STATE: CA ZIP: 92037 </SEC-HEADER> <DOCUMENT> <TYPE>DEFM14A <SEQUENCE>1 <FILENAME>ny20005542x1_defm14a.htm <DESCRIPTION>DEFM14A <TEXT> Document 1 - file: ny20005542x1_defm14a.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>ny20005542x1_equilliumlogo.jpg <TEXT> Document 2 - file: ny20005542x1_equilliumlogo.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>ny20005542x1_equilliumlx1.jpg <TEXT> Document 3 - file: ny20005542x1_equilliumlx1.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>ny20005542x1_metacrinelogo.jpg <TEXT> Document 4 - file: ny20005542x1_metacrinelogo.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>ny20005542x1_metacrinelx1.jpg <TEXT> Document 5 - file: ny20005542x1_metacrinelx1.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>ny20005542x1_pc01.jpg <TEXT> Document 6 - file: ny20005542x1_pc01.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>ny20005542x1_pc02.jpg <TEXT> Document 7 - file: ny20005542x1_pc02.jpg
</DOCUMENT> </SEC-DOCUMENT>